|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02186 LUYE PHARMA
Nominal 
3.660 -0.150 (-3.937%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 167,764 | 1,595,487 | 1,653,796 | 182,371 |
| Net Cash from / (used in) Investing Activities | -- | (1,471,256) | (1,418,258) | (1,658,308) | (3,436,032) |
| Net Cash from / (used in) Financing Activities | -- | 2,956,257 | 841,599 | 54,148 | 1,878,897 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 1,652,765 | 1,018,828 | 49,636 | (1,374,764) |
| Cash & Cash Equivalents at beginning of period | -- | 3,238,973 | 2,323,740 | 2,438,252 | 3,865,385 |
| Effect of Foreign Exchange Rate Changes | -- | 45,407 | (103,595) | (164,148) | (52,369) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 4,937,145 | 3,238,973 | 2,323,740 | 2,438,252 |
| Remarks: | Real time quote last updated: 10/09/2025 12:09 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 312,886 |
| %Change | -19.325% |
| EPS / (LPS) | RMB 0.083 |
| NBV Per Share (¥) | RMB 3.906 |